Phytopharm PLC
20 April 2005
Re: Disclosure of interests in shares
In accordance with Section 198-202 of the UK Companies Act 1985, FMR Corp, the
parent holding of Fidelity Management & Research Company (FMRCO), and Fidelity
International Limited (FIL) informed us on 20 April 2005 that it and its
subsidiary companies, including Fidelity Investment Services Ltd (FISL) and Mr
Edward C Johnson 3rd of 82 Devonshire Street, Boston MA 02109, a principal
shareholder of FMR Corp and FIL, no longer have a notifiable interest in the
ordinary shares of Phytopharm plc based on an issued share capital of 43,099,700
ordinary shares
This information is provided by RNS
The company news service from the London Stock Exchange
BLFLEZBXBBB
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.